The bioenergetic signature of lung adenocarcinomas is a molecular marker of cancer diagnosis and prognosis

Carcinogenesis

Volumn 25, Issue 7, 2004, Pages 1157-1163

  Cuezva, José M ^a   Chen, Guoan ^b   Alonso, Andrés M ^a   Isidoro, Antonio ^a   Misek, David E ^b   Hanash, Samir M ^b   Beer, David G ^b  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN 60; ISOENZYME; MOLECULAR MARKER; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE BETA; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; BIOENERGY; BRONCHUS TUMOR; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CLASSIFICATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FOLLOW UP; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL CARCINOMA; LUNG CARCINOGENESIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MITOCHONDRION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY ANALYSIS; SURVIVAL RATE; TUMOR DIFFERENTIATION; TUMOR VOLUME; TWO DIMENSIONAL ELECTROPHORESIS; VALIDATION PROCESS;

ADENOCARCINOMA; BIOLOGICAL MARKERS; CHAPERONIN 60; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ENERGY METABOLISM; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; ISOENZYMES; LUNG NEOPLASMS; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; TIME FACTORS;

EID: 3242753586     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/bgh113     Document Type: Review

References (41)

1. Fry,W.A., Phillips,J.L. and Menck,H.R. (1999) Ten-year survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer, 86, 1867-1876.
2. Mountain,C.F. (2000) The international system for staging lung cancer. Semin. Surg. Oncol., 18, 106-115.
3. Mountain,C.F. (2002) Staging classification of lung cancer. A critical evaluation. Clin. Chest Med., 23, 103-121.
4. Ramaswamy,S. and Golub,T.R. (2002) DNA microarrays in clinical oncology. J. Clin. Oncol., 20, 1932-1941.
5. Petricoin,E.F., Zoon,K.C., Kohn,E.C., Barrett,J.C. and Liotta,L.A. (2002) Clinical proteomics: translating benchside promise into bedside reality. Nature Rev. Drug Discov., 1, 683-695.
6. Beer,D.G., Kardia,S.L., Huang,C.C. et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Med., 8, 816-824.
7. Wulfkuhle,J.D., Liotta,L.A. and Petricoin,E.F. (2003) Proteomic applications for the early detection of cancer. Nature Rev. Cancer, 3, 267-275.
8. Chen,G., Gharib,T.G., Huang,C.C. et al. (2002) Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin. Cancer Res., 8, 2298-2305.
9. Ramaswamy,S., Ross,K.N., Lander,E.S. and Golub,T.R. (2003) A molecular signature of metastasis in primary solid tumors. Nature Genet., 33, 49-54.
10. Liotta,L.A. and Kohn,E.C. (2003) Cancer's deadly signature. Nature Genet., 33, 10-11.
11. Boyer,P.D. (1997) The ATP synthase. A splendid molecular machine. Annu. Rev. Biochem., 66, 717-749.
12. Yoshida,M., Muneyuki,E. and Hisabori,T. (2001) ATP synthase - a marvellous rotary engine of the cell. Nature Rev. Mol. Cell Biol., 2, 669-677.
13. Dey,R. and Moraes,C.T. (2000) Lack of oxidative phosphorylation and low mitochondrial membrane potential decrease susceptibility to apoptosis and do not modulate the protective effect of Bcl-x (L) in osteosarcoma cells. J. Biol. Chem., 275, 7087-7094.
14. Harris,M.H., Vander Heiden,M.G., Kron,S.J. and Thompson,C.B. (2000) Role of oxidative phosphorylation in Bax toxicity. Mol. Cell. Biol., 20, 3590-3596
15. Matsuyama,S., Xu,Q., Velours,J. and Reed,J.C. (1998) The Mitochondrial F0F1-ATPase proton pump is required for function of the propoptotic protein Bax in yeast and mammalian cells. Mol. Cell, 1, 327-336.
16. Reed,J.C. (1999) Mechanisms of apoptosis avoidance in cancer. Curr. Opin. Oncol., 11, 68-75.
17. Hanahan,D. and Weinberg,R.A. (2000) The hallmarks of cancer. Cell, 100, 57-70.
18. Cuezva,J.M., Krajewska,M., López de Heredia,M., Krajewski,S., Santamaría,G., Kim,H., Zapata,J.M., Marusawa,H., Chamorro,M. and Reed,J.C. (2002) The bioenergetic signature of cancer: a marker of tumor progression. Cancer Res., 62, 6674-6681.
19. Warburg,O. (1930) Metabolism of Tumors. Arnold Constable, London.
20. Ali,I., Chan,Y., Kuick,R., Teichroew,D. and Hanash,S.M. (1991) Implementation of a two-dimensional electrophoresis-related laboratory information processing system: database aspects. Electrophoresis, 12, 747-761.
21. Kuick,R.D., Skolnick,M.M., Hanash,S.M. and Neel,J.V. (1991) A two-dimensional electrophoresis-related laboratory information processing system: spot matching. Electrophoresis, 12, 736-746.
22. Daniel,W.W. (1990) Applied Nonparametric Statistics. PSW-KENT Publishing Company, Boston.
23. Johnson,R.A. and Wichern,D.W. (1992) Applied Multivariate Statistical Analysis. Prentice-Hall, New Jersey.
24. Lachenbruch,P.A. and Mickey,M.R. (1968) Estimation of error rates in discriminant analysis. Technometrics, 10, 1-11.
25. Cox,D.R. and Oakes,D. (1988) Analysis of Survival Data. Chapman and Hall Ltd, London.
26. Iyengar,P. and Tsao,M.S. (2002) Clinical relevance of molecular markers in lung cancer. Surg. Oncol., 11, 167-179.
27. Mao,L. (2002) Recent advances in the molecular diagnosis of lung cancer. Oncogene, 21, 6960-6969.
28. Wu,J.T. (1999) Review of circulating tumor markers: from enzyme, carcinoembryonic protein to oncogene and suppressor gene. Ann. Clin. Lab. Sci., 29, 106-111.
29. Warburg,O. (1956) On the origin of cancer cells. Science, 123, 309-314.
30. Lopez-Encuentra,A., Bulzebruck,H., Feinstein,A.R., Motta,G., Mountain,C.F., Naruke,T., Sanchez,J.M., Tsuchiya,R. and Wittekind,C. (2000) Tumor staging and classification in lung cancer. Lung Cancer, 29, 79-83.
31. Izquierdo,J.M., Ricart,J., Ostronoff,L.K., Egea,G. and Cuezva,J.M. (1995) Changing patterns of transcriptional and post-transcriptional control of beta-F1-ATPase gene expression during mitochondrial biogenesis in liver. J. Biol. Chem., 270, 10342-10350.
32. Izquierdo,J.M. and Cuezva,J.M. (1997) Control of the translational efficiency of beta-F1-ATPase mRNA depends on the regulation of a protein that binds the 3′ untranslated region of the mRNA. Mol. Cell. Biol., 17, 5255-5268.
33. Hayakawa,M., Sakashita,E., Ueno,E., Tominaga,S., Hamamoto,T., Kagawa,Y. and Endo,H. (2002) Muscle-specific exonic splicing silencer for exon exclusion in human ATP synthase gamma-subunit pre-mRNA. J. Biol. Chem., 277, 6974-6984.
34. Jordan,E.M., Worley,T. and Breen,G.A. (2003) Transcriptional regulation of the nuclear gene encoding the alpha-subunit of the mammalian mitochondrial F1F0 ATP synthase complex: role for the orphan nuclear receptor, COUP-TFII/ARP-1. Biochemistry, 42, 2656-2663.
35. Jin,Y., Suzuki,H., Maegawa,S., Endo,H., Sugano,S., Hashimoto,K., Yasuda,K. and Inoue,K. (2003) A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. EMBO J., 22, 905-912.
36. Luis,A.M., Izquierdo,J.M., Ostronoff,L.K., Salinas,M., Santarén,J.F. and Cuezva,J.M. (1993) Translational regulation of mitochondrial differentiation in neonatal rat liver. Specific increase in the translational efficiency of the nuclear-encoded mitochondrial beta-F1-ATPase mRNA. J. Biol. Chem., 268, 1868-1875.
37. +-ATP synthase requires the participation of two distal cis-acting elements and a complex set of cellular transacting proteins. Biochem. J., 365, 417-428.
38. Cuezva,J.M., Ostronoff,L.K., Ricart,J., López de Heredia,M., Di Liegro,C.M. and Izquierdo,J.M. (1997) Mitochondrial biogenesis in the liver during development and oncogenesis. J. Bioenerg. Biomembr., 29, 365-377.
39. López de Heredia,M., Izquierdo,J.M. and Cuezva,J.M. (2000) A conserved mechanism for controlling the translation of beta-F1-ATPase mRNA between the fetal liver and cancer cells. J. Biol. Chem., 275, 7430-7437.
40. Lal,A., Lash,A.E., Altschul,S.F. et al. (1999) A public database for gene expression in human cancers. Cancer Res., 59, 5403-5407.
41. Chen,G., Gharib,T.G., Huang,C.C. et al. (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell Proteomics, 1, 304-313.